Notably, our study also revealed a positive correlation between VEGF expression and CD47 in gastric cancer tissues, suggesting the potential efficacy of combining anti-CD47 and anti-angiogenesis therapies for the treatment of gastric cancer in clinical settings. This evidence concerns the gene VEGFA and gastric cancer.